Skip to main content
← Back to companies
BillionToOne logo

BillionToOne

4 open
Menlo Park, CA, USAFounded 2016300+ employeesSeries B+ raisedSeries B+BLLN
Last round: series d · $130M · Jun 2024(8 rounds total)
The genetic testing platform detecting and measuring disease.
Backed by(32 investors)
Adams Street PartnersPremji InvestHummingbird VenturesBridge Banke2vcNeotribe VenturesEczacıbaşı MomentumBaillie GiffordCivilization VenturesNeuberger BermanLibertus CapitalFifty YearsNorwestY Combinator500 Global

The genetic testing platform detecting and measuring disease.

YC S17

About the Company

Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives?

BillionToOne, one of the top Y Combinator companies with $200M+ in funding from prominent VC firms, has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold. We are the only technology platform that can detect single-gene disorders in an unborn baby from maternal blood and that can accurately quantify tumor DNA changes in cancer patients.

UNITY Screen, our prenatal test, continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy products, which will transform oncology care.

Tech Stack

Software tech stack

  • Python
  • Django / django rest framework
  • Postgres
  • Heroku

DNA sequencing tech stack

  • High throughput next-generation sequencing
  • Sanger sequencing
  • PCR
  • Genome Analysis Toolkit / samtools / bedtools
  • AWS

Founders

Oguzhan Atay
Oguzhan Atay
David Tsao
David Tsao

Ready to start your space career at BillionToOne?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo